Quarterly report [Sections 13 or 15(d)]

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.25.3
Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 63,140,993 85,137,168 63,140,993 85,137,168
Common stock warrants        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 14,367,942 28,783,069 14,367,942 28,783,069
Unvested restricted stock awards        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 40,295,737 42,928,074 40,295,737 42,928,074
Options to purchase common stock and unvested restricted stock awards        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 8,477,314 13,426,025 8,477,314 13,426,025